资讯

Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General ...
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...
Tri-City Herald8 天
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General ...
Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs. Jaguar is exploring ...
Investing8 天
Jaguar Health seeks EU approval for dog diarrhea treatment
SAN FRANCISCO - Jaguar Health, Inc. (NASDAQ:JAGX) plans to pursue European regulatory approval for its canine diarrhea treatment Canalevia, according to a company statement released Wednesday. The ...
The Indianapolis Star9 天
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of ... - IndyStar
Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs. Jaguar is exploring ...